Effects of metergoline on symptoms in women with premenstrual dysphoric disorder

American Journal of Psychiatry

Volumn 159, Issue 11, 2002, Pages 1876-1881

  Roca, Catherine A ^a   Schmidt, Peter J ^a   Smith, Mark J ^a   Danaceau, Merry A ^a   Murphy, Dennis L ^a   Rubinow, David R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; FLUOXETINE; METERGOLINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MOOD; OUTCOMES RESEARCH; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM; SYMPTOM;

ADULT; AFFECT; DEPRESSION; DIPHENHYDRAMINE; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; METERGOLINE; PERSONALITY INVENTORY; PREMENSTRUAL SYNDROME; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0036842555     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.11.1876     Document Type: Article

References (28)

1. Rubinow DR, Schmidt PJ: The neurobiology of menstrual cycle-related mood disorders, in Neurobiology of Mental Illness. Edited by Charney DS, Nestler EJ, Bunney BS. New York, Oxford University Press, 1999, pp 907-914
2. Wikander K, Sundblad C, Andersch B, Dagnell I, Zylberstein D, Bengtsson F, Eriksson E: Citalopram in premenstrual dysphoria: Is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycie? J Clin Psychopharmacol 1998; 18:390-398
3. Lesch KP, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL: Regional brain expression of serotonin transporter messenger-RNA and its regulation by reuptake inhibiting antidepressants. Mol Brain Res 1993; 17:31-35
4. 2C serotonin receptors by fluoxetine (Prozac). Proc Natl Acad Sci USA 1997; 94:2036-2040
5. Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A: Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 1998; 95:3239-3244
6. 1C receptors and their therapeutic relevance. Curr Opin Invest Drugs 1993; 2:317-362
7. Fuxe K, Agnati L, Everitt B: Effects of metergoline on central monoamine neurons: Evidence for a selective blockade of central 5-HT receptors. Neurosci Lett 1975; 1:283-290
8. Greenberg BD, Benjamin J, Martin JD, Keuler D, Huang SJ, Altemus M, Murphy DL: Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients. Psychopharmacology (Berl) 1998; 140:434-444
9. Su T-P, Schmidt PJ, Danaceau M, Murphy DL, Rubinow DR: Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 1997; 82:1220-1228
10. Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL: Serotonergic responsivity in obsessive-compulsive disorder: Comparison of patients and healthy controls. Arch Gen Psychiatry 1987; 44:946-951
11. Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH: Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Arch Gen Psychiatry 1994; 51:309-317
12. Menkes DB, Coates DC, Fawcett JP: Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord 1994; 32: 37-44
13. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R - Patient Version (SCID-P). New York, New York State Psychiatric Institute, Biometrics Research, 1990
14. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCIDP), Version 2. New York, New York State Psychiatric Institute, Biometrics Research, 1995
15. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571
16. Steiner M, Haskett RF, Carroll BJ: Premenstrual tension syndrome: The development of research diagnostic criteria and new rating scales. Acta Psychiatr Scand 1980; 62:177-190
17. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55
18. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
19. Van Kammen DP, Murphy DL: Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 1975; 44:215-224
20. Rubinow DR, Berrettini CH, Brouwers P, Lane HC: Neuropsychiatric consequences of AIDS. Ann Neurol 1988; 23:S24-S26
21. Schnurr PP: Measuring amount of symptom change in the diagnosis of premenstrual syndrome. Psychol Assess 1989; 1: 277-283
22. Krulich L, McCann SM, Mayfield MA: On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine. Endocrinology 1981; 108:1115-1124
23. Aubert ML, Becker RL, Saxena BB, Raiti S: Report of the National Pituitary Agency: Collaborative study of the radioimmunoassay of human prolactin. J Clin Endocrinol Metab 1974; 38: 1115-1120
24. Sundblad C, Hedberg MA, Eriksson E: Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: A placebo-controlled trial. Neuropsychopharmacology 1993; 9:133-145
25. Guidotti A, Costa E: Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability? Biol Psychiatry 1998; 44: 865-873
26. 1C receptor reserve in choroid plexus masks receptor subsensitivity. J Pharmacol Exp Ther 1990; 252:984-988
27. A receptors in the dorsal hippocampus of rats. J Psychiatr Neurosci 1993; 18:264-275
28. Roca CA, Schmidt PJ, Greenberg BD, Murphy DL, Rubinow DR: Serotonin and the efficacy of estrogen in perimenopausal depression (abstract). Biol Psychiatry 1999; 45(suppl):76S